Frazier Lifesciences Acquisition : CONDENSED CONSOLIDATED ST

CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS









For the six months ended June 30,


...

Related Keywords

Gooimeer , Netherlands General , Netherlands , Italy , United States , Naarden , Noord Holland , Dutch , Michael Davidson , Newamsterdam Pharma , Company Long , Development Expense , Group Information , Foreign Exchange Ratesand , International Financial Reporting Standards , Nasdaq , International Accounting Standards Board , Company Options , Company Annual Report On Form , Company The Ordinary , Frazier Life Sciences Acquisition Corp , Company Supplementary Long , Senior Managers Of The Company , Group To Menarini , Exchange Commission On , Company Rollover Option Plan The , Newamsterdam Pharma Company , Annual Report , Exchange Commission , Material Accounting Policy , Financial Reportingand , United States Dollar , Amendments Issued , Not Yet Adopted , Menarini License , Liabilities Fair , Placement Warrants , Private Placement Warrants , Ordinary Share , Business Combination Agreement , Earnout Shares , Participating Optionholder , Participating Shareholders , Public Warrants , Long Term Incentive Plan , Supplementary Long Term Incentive Plan , Rollover Option Plan , Supplementary Plan , Ordinary Shares , Company Option , Based Payment Expenses Recognized , Stock Units , Participating Optionholders , Positive Phase , Depositary Receipts , Amsterdam Pharma , Amsterdam Pharma Options , Senior Managers , Management Personnel , Chief Executive Officer , Chief Financial Officer , Chief Science Officer , Chief Operating Officer , Chief Business Officer , Vice President , Development The , Chief Operating Decision Maker , Markets ,